Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The environment and disease: association or causation?
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Laquinimod
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
CD4 cell response to interval therapy with natalizumab.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Multiple sclerosis treatment: current best practice.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.

Pages